Stylus Medicine

Drug Discovery · Cambridge, MA · Founded 2022 · Privately Held (backing)

Developer of in vivo genetic medicines designed to enable precise insertion of therapeutic genetic material within the human genome. Stylus Medicine is based in Cambridge, MA and was founded in 2022. It was valued at $114 million at its early-stage round in May 2025, the last priced event on record. It has raised $93 million across 1 recorded round; the latest was an $85 million Series A in May 2025.

PMV mark · valuation
$114.0M
Oct 2026
Priced at
its early-stage round
May 2025
Total raised
$93.0M
Last round
Early Stage VC (Series A)
May 2025

Who backs Stylus Medicine?

12 investors
InvestorType
Khosla VenturesVenture capital
RA Capital ManagementAsset manager
University of CaliforniaOther
Johnson & Johnson JJDCVenture capital
Brainstorm VenturesVenture capital
NEVA SGRVenture capital
Berkeley—
California Innovation Fund—
Chugai Venture Fund—
Eli Lilly—
+ 2 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Stylus Medicine investors

12 investors are on record for Stylus Medicine, including Khosla Ventures, RA Capital Management, University of California and Johnson & Johnson JJDC. By type, the record holds 4 venture capital firms and 1 asset manager. The Series A in May 2025 drew 9 investors.

Free account
More of Stylus Medicine with a free account
  • ·The complete investor list: 12 names
  • ·Watch Stylus Medicine: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 12 firms already write checks for companies like Stylus Medicine in drug discovery. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View